Circulating tumor DNA dynamics predict survival in metastatic colorectal cancer

◇ RESEARCH

In a study of 1,391 patients, those with persistent or acquired RAS and BRAF mutations in ctDNA had significantly worse overall survival than patients who maintained wild-type status, suggesting liquid biopsy monitoring may help refine treatment strategies. (iScience)